Digoxin Tablet
Product Images NDC 0904-5921

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 0904-5921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C97d2c6b 8c11 4d67 B951 Cb748c1daac2 00

This is a description of a medication called Digoxin. The medication comes in tablet form with each tablet containing 250 mcg (0.25 mg) of the active ingredient. The tablets are available for R-only and come presented as 100 tablets in a unit dose. However, some of the text is not readable, making it difficult to provide a detailed description of the medication.*

FDA Label Image

C97d2c6b 8c11 4d67 B951 Cb748c1daac2 01

This is a medication package of Digoxin tablets, USP with NDC 0904-5921-61 and 10 tablets in a unit dose. Each scored tablet contains 125 mcg (0.125 mg) of Digoxin, USP 025 g. The typical adult dosage is mentioned, and it is indicated for people suffering from riomatin, rocaens, and similar conditions. The package is child-resistant, and the medication should be kept out of children's reach. The text on the package suggests that it is intended for national use and is manufactured by West Ward Pharmaceuticals in Eatonton, N 57728.*

FDA Label Image

Structural Image (Digoxin Tablet 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.